Pharmacological treatments of non-substance-withdrawal delirium: A systematic review of prospective trials

American Journal of Psychiatry

Volumn 171, Issue 2, 2014, Pages 151-159

  Friedman, Joseph I ^a,b,c   Soleimani, Laili ^a,b,c   McGonigle, Daniel P ^a,b,c   Egol, Claudine ^a,b,c   Silverstein, Jeffrey H ^a,b,c  

^a Department of Psychiatry ^*  (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Pilgrim Psychiatric Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; DONEPEZIL; GABAPENTIN; HALOPERIDOL; KETAMINE; LORAZEPAM; MELATONIN; MIDAZOLAM; MORPHINE; NEUROLEPTIC AGENT; OLANZAPINE; PROPOFOL; RISPERIDONE; RIVASTIGMINE;

CLINICAL EFFECTIVENESS; DELIRIUM; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERGLYCEMIA; ILIAC FASCIA BLOCK; LENGTH OF STAY; MORTALITY; NERVE BLOCK; NEUROPROTECTION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

ANALGESICS; ANESTHETICS, LOCAL; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS AS TOPIC; DELIRIUM; HUMANS; HYPNOTICS AND SEDATIVES;

EID: 84893691264     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2013.13040458     Document Type: Review

References (65)

1. Inouye SK, Viscoli CM, Horwitz RI, Hurst LD, Tinetti ME: A predictive model for delirium in hospitalized elderly medical patients based on admission characteristics. Ann Intern Med 1993; 119:474-481
2. Inouye SK, Charpentier PA: Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability. JAMA 1996; 275:852-857
3. Inouye SK, Bogardus ST Jr, Charpentier PA, Leo-Summers L, Acampora D, Holford TR, Cooney LM Jr: A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340:669-676
4. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 2009; 339:b2700
5. Wang W, Li HL, Wang DX, Zhu X, Li SL, Yao GQ, Chen KS, Gu XE, Zhu SN: Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: A randomized controlled trial. Crit Care Med 2012; 40:731-739
6. Kaneko T, Cai J, Ishikura KT, Cai J, Ishikura T, Kobayashi M: Prophylactic consecutive administration of haloperidol can reduce the occurrence of postoperative delirium in gastrointestinal surgery. Yonago Acta Med 1999; 42:179-184
7. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, Vreeswijk R, Egberts TC, Burger BJ, Eikelenboom P, van Gool WA: Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. J Am Geriatr Soc 2005; 53:1658-1666
8. Prakanrattana U, Prapaitrakool S: Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care 2007; 35:714-719
9. Hakim SM, Othman AI, Naoum DO: Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: A randomized trial. Anesthesiology 2012; 116:987-997
10. Larsen KA, Kelly SE, Stern TA, Bode RH Jr, Price LL, Hunter DJ, Gulczynski D, Bierbaum BE, Sweeney GA, Hoikala KA, Cotter JJ, Potter AW: Administration of olanzapine to prevent postoperative delirium in elderly joint-replacement patients: A randomized, controlled trial. Psychosomatics 2010; 51:409-418
11. Liptzin B, Laki A, Garb JL, Fingeroth R, Krushell R: Donepezil in the prevention and treatment of post-surgical delirium. Am J Geriatr Psychiatry 2005; 13:1100-1106
12. Sampson EL, Raven PR, Ndhlovu PN, Vallance A, Garlick N, Watts J, Blanchard MR, Bruce A, Blizard R, Ritchie CW: A randomized, double-blind, placebo-controlled trial of donepezil hydrochloride (Aricept) for reducing the incidence of postoperative delirium after elective total hip replacement. Int J Geriatr Psychiatry 2007; 22:343-349
13. Marcantonio ER, Palihnich K, Appleton P, Davis RB: Pilot randomized trial of donepezil hydrochloride for delirium after hip fracture. J Am Geriatr Soc 2011; 59(suppl 2):S282-S288
14. Zaslavsky A, Haile M, Kline R, Iospa A, Frempong-Boadu A, Bekker A: Rivastigmine in the treatment of postoperative delirium: A pilot clinical trial. Int J Geriatr Psychiatry 2012; 27: 986-988
15. Gamberini M, Bolliger D, Lurati Buse GA, Burkhart CS, Grapow M, Gagneux A, Filipovic M, Seeberger MD, Pargger H, Siegemund M, Carrel T, Seiler WO, Berres M, Strebel SP, Monsch AU, Steiner LA: Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery-a randomized controlled trial. Crit Care Med 2009; 37:1762-1768
16. Berggren D, Gustafson Y, Eriksson B, Bucht G, Hansson LI, Reiz S, Winblad B: Postoperative confusion after anesthesia in elderly patients with femoral neck fractures. Anesth Analg 1987; 66: 497-504
17. Papaioannou A, Fraidakis O, Michaloudis D, Balalis C, Askitopoulou H: The impact of the type of anaesthesia on cognitive status and delirium during the first postoperative days in elderly patients. Eur J Anaesthesiol 2005; 22:492-499
18. Beaussier M, Weickmans H, Parc Y, Delpierre E, Camus Y, Funck-Brentano C, Schiffer E, Delva E, Lienhart A: Postoperative analgesia and recovery course after major colorectal surgery in elderly patients: A randomized comparison between intrathecal morphine and intravenous PCA morphine. Reg Anesth Pain Med 2006; 31:531-538
19. Mouzopoulos G, Vasiliadis G, Lasanianos N, Nikolaras G, Morakis E, Kaminaris M: Fascia iliaca block prophylaxis for hip fracture patients at risk for delirium: A randomized placebo-controlled study. J Orthop Traumatol 2009; 10:127-133
20. Leung JM, Sands LP, Rico M, Petersen KL, Rowbotham MC, Dahl JB, Ames C, Chou D, Weinstein P: Pilot clinical trial of gabapentin to decrease postoperative delirium in older patients. Neurology 2006; 67:1251-1253
21. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-499
22. Maldonado JR, Wysong A, van der Starre PJ, Block T, Miller C, Reitz BA: Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics 2009; 50: 206-217
23. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298:2644-2653
24. Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, Chen J: Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: A randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). Anesthesiology 2009; 111:1075-1084
25. Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y: Delirium in an intensive care unit: A study of risk factors. Intensive Care Med 2001; 27:1297-1304
26. Ersek M, Cherrier MM, Overman SS, Irving GA: The cognitive effects of opioids. Pain Manag Nurs 2004; 5:75-93
27. Sieber FE, Zakriya KJ, Gottschalk A, Blute MR, Lee HB, Rosenberg PB, Mears SC: Sedation depth during spinal anesthesia and the development of postoperative delirium in elderly patients undergoing hip fracture repair. Mayo Clin Proc 2010; 85:18-26; correction, 2010; 85:400
28. Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Byrne AJ, Hudetz AG, Warltier DC, Pagel PS: Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth 2009; 23:651-657
29. Al-Aama T, Brymer C, Gutmanis I, Woolmore-Goodwin SM, Esbaugh J, Dasgupta M: Melatonin decreases delirium in elderly patients: A randomized, placebo-controlled trial. Int J Geriatr Psychiatry 2011; 26:687-694
30. Girard TD, Pandharipande PP, Carson SS, Schmidt GA, Wright PE, Canonico AE, Pun BT, Thompson JL, Shintani AK, Meltzer HY, Bernard GR, Dittus RS, Ely EW; MIND Trial Investigators: Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: The MIND randomized, placebo-controlled trial. Crit Care Med 2010; 38:428-437
31. Devlin JW, Roberts RJ, Fong JJ, Skrobik Y, Riker RR, Hill NS, Robbins T, Garpestad E: Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med 2010; 38:419-427
32. Tahir TA, Eeles E, Karapareddy V, Muthuvelu P, Chapple S, Phillips B, Adyemo T, Farewell D, Bisson JI: A randomized controlled trial of quetiapine versus placebo in the treatment of delirium. J Psychosom Res 2010; 69:485-490
33. Boettger S, Friedlander M, Breitbart W, Passik S: Aripiprazole and haloperidol in the treatment of delirium. Aust NZ J Psychiatry 2011; 45:477-482
34. Skrobik YK, Bergeron N, Dumont M, Gottfried SB: Olanzapine vs haloperidol: Treating delirium in a critical care setting. Intensive Care Med 2004; 30:444-449
35. Sipahimalani A, Masand PS: Olanzapine in the treatment of delirium. Psychosomatics 1998; 39:422-430
36. Grover S, Kumar V, Chakrabarti S: Comparative efficacy study of haloperidol, olanzapine and risperidone in delirium. J Psychosom Res 2011; 71:277-281
37. Han CS, Kim YK: A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 2004; 45: 297-301
38. Breitbart W, Marotta R, Platt MM, Weisman H, Derevenco M, Grau C, Corbera K, Raymond S, Lund S, Jacobson P: A doubleblind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 1996; 153:231-237
39. Kim SW, Yoo JA, Lee SY, Kim SY, Bae KY, Yang SJ, Kim JM, Shin IS, Yoon JS: Risperidone versus olanzapine for the treatment of delirium. Hum Psychopharmacol 2010; 25:298-302
40. Lee KU, Won WY, Lee HK, Kweon YS, Lee CT, Pae CU, Bahk WM: Amisulpride versus quetiapine for the treatment of delirium: A randomized, open prospective study. Int Clin Psychopharmacol 2005; 20:311-314
41. van Eijk MM, Roes KC, Honing ML, Kuiper MA, Karakus A, van der Jagt M, Spronk PE, van Gool WA, van der Mast RC, Kesecioglu J, Slooter AJ: Effect of rivastigmine as an adjunct to usual care with haloperidol on duration of delirium and mortality in critically ill patients: A multicentre, double-blind, placebo-controlled randomised trial. Lancet 2010; 376:1829-1837
42. Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R: Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: A randomised open-label trial. Crit Care 2009; 13: R75
43. Pae CU, Lee SJ, Lee CU, Lee C, Paik IH: A pilot trial of quetiapine for the treatment of patients with delirium. Hum Psychopharmacol 2004; 19:125-127
44. Kim KY, Bader GM, Kotlyar V, Gropper D: Treatment of delirium in older adults with quetiapine. J Geriatr Psychiatry Neurol 2003; 16:29-31
45. Breitbart W, Tremblay A, Gibson C: An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 2002; 43:175-182
46. Zhang Z, Pan L, Ni H: Impact of delirium on clinical outcome in critically ill patients: A meta-analysis. Gen Hosp Psychiatry 2013; 35:105-111
47. Jackson JC, Gordon SM, Hart RP, Hopkins RO, Ely EW: The association between delirium and cognitive decline: A review of the empirical literature. Neuropsychol Rev 2004; 14:87-98
48. MacLullich AM, Beaglehole A, Hall RJ, Meagher DJ: Delirium and long-term cognitive impairment. Int Rev Psychiatry 2009; 21: 30-42
49. Lundström M, Edlund A, Bucht G, Karlsson S, Gustafson Y: Dementia after delirium in patients with femoral neck fractures. J Am Geriatr Soc 2003; 51:1002-1006
50. Morandi A, Rogers BP, Gunther ML, Merkle K, Pandharipande P, Girard TD, Jackson JC, Thompson J, Shintani AK, Geevarghese S, Miller RR 3rd, Canonico A, Cannistraci CJ, Gore JC, Ely EW, Hopkins RO VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae: The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: The VISIONS prospective cohort magnetic resonance imaging study. Crit Care Med 2012; 40:2182-2189
51. Gunther ML, Morandi A, Krauskopf E, Pandharipande P, Girard TD, Jackson JC, Thompson J, Shintani AK, Geevarghese S, Miller RR 3rd, Canonico A, Merkle K, Cannistraci CJ, Rogers BP, Gatenby JC, Heckers S, Gore JC, Hopkins RO, Ely EW VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae: The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: The VISIONS cohort magnetic resonance imaging study. Crit Care Med 2012; 40:2022-2032
52. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, Gordon SM, Canonico AE, Dittus RS, Bernard GR, Ely EW: Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010b; 38:1513-1520
53. Neufeld KJ, Leoutsakos JM, Sieber FE, Wanamaker BL, Gibson Chambers JJ, Rao V, Schretlen DJ, Needham DM: Outcomes of early delirium diagnosis after general anesthesia in the elderly. Anesth Analg 2013; 117:471-478
54. Meagher D, Adamis D, Trzepacz P, Leonard M: Features of subsyndromal and persistent delirium. Br J Psychiatry 2012; 200:37-44
55. Marcantonio ER, Kiely DK, Simon SE, John Orav E, Jones RN, Murphy KM, Bergmann MA: Outcomes of older people admitted to postacute facilities with delirium. J Am Geriatr Soc 2005; 53:963-969
56. Cole M, McCusker J, Dendukuri N, Han L: The prognostic significance of subsyndromal delirium in elderly medical inpatients. J Am Geriatr Soc 2003; 51:754-760
57. Lawlor P, Gagnon B, Mancini IL, Pereira J, Bruera E: Phenomenology of delirium and its subtypes in advanced cancer patients: A prospective study (abstract). Palliat Care 1998; 14: 106
58. Webster R, Holroyd S: Prevalence of psychotic symptoms in delirium. Psychosomatics 2000; 41:519-522
59. Liptzin B, Levkoff SE: An empirical study of delirium subtypes. Br J Psychiatry 1992; 161:843-845
60. Inouye SK: The dilemma of delirium: Clinical and research controversies regarding diagnosis and evaluation of delirium in hospitalized elderly medical patients. Am J Med 1994; 97: 278-288
61. American Psychiatric Association: Practice Guideline for the Treatment of Patients With Delirium. Am J Psychiatry 1999; 156 (May suppl):1-20
62. National Institute for Health and Clinical Excellence: Delirium: Diagnosis, Prevention and Management: Clinical Guideline 103. http://guidance.nice.org.uk/CG103.
63. Clinical Epidemiology and Health Service Evaluation Unit, Victoria, Australia: Clinical Practice Guidelines for the Management of Delirium in Older People, October 2006. http://docs.health. vic.gov.au/docs/doc/Clinical-Practice- Guidelines-for-the-Management- of-Delirium-in-Older-People-October-2006
64. O'Keeffe ST: Clinical subtypes of delirium in the elderly. Dement Geriatr Cogn Disord 1999; 10:380-385
65. Platt MM, Breitbart W, Smith M, Marotta R, Weisman H, Jacobsen PB: Efficacy of neuroleptics for hypoactive delirium. J Neuropsychiatry Clin Neurosci 1994; 6:66-67